Market Overview:
The global defibrillators market size reached US$ 5.1 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 7.4 Billion by 2028, exhibiting a growth rate (CAGR) of 6.6% during 2023-2028.
A defibrillator refers to a medical device that delivers a therapeutic shock to the patient’s heart in life-threatening conditions, such as ventricular fibrillation, cardiac arrhythmia and pulseless ventricular tachycardia. It aids in restoring a normal heartbeat by sending electric pulses or shockwaves to the heart. Some of the common types of defibrillators include automated external defibrillators (AED), manual/wearable external defibrillators, implantable cardioverter defibrillators (ICDs) and transvenous or subcutaneous implantable cardioverter defibrillators. These devices are primarily used in hospitals, clinics, cardiac centers, home care settings and prehospital care settings.
The increasing prevalence of cardiovascular diseases (CVDs) and sudden cardiac arrest (SCA) across the globe is one of the key factors driving the growth of the market. Such disorders are highly prevalent among the geriatric population and individuals suffering from other related ailments, such as diabetes, atherosclerosis, hypertension and stroke, which is facilitating the product adoption across both the developed and emerging nations. Furthermore, widespread adoption of ICDs across healthcare centers is also providing a boost to the market growth. Modern ICDs are integrated with innovative subcutaneous and transvenous patches that aid in improving the overall efficiency and level of comfort for the patient. Additionally, various technological advancements and the development of wearable cardioverter defibrillators (WCDs) that can aid in predicting the risks of SCAs, are also creating a positive impact on the market growth. Other factors, including the implementation of favorable policies to promote training and awareness regarding defibrillators, along with extensive research and development (R&D) activities and increasing government investments in the healthcare sector, are projected to drive the market further.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global defibrillators market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on product type and end-user.
Breakup by Product Type:
- Implantable Defibrillators
- Transvenous Implantable Cardioverter Defibrillator (T-ICDs)
- Subcutaneous Implantable Cardioverter Defibrillator (S-ICDs)
- Cardiac Resynchronization Therapy- Defibrillator (CRT-D)
- External Defibrillators
- Manual External Defibrillator
- Automated External Defibrillator (AEDs)
- Wearable Cardioverter Defibrillator (WCDs)
Breakup by End-User:
- Hospitals and Clinics
- Prehospital Care Settings
- Cardiac Centers
- Homecare Settings
- Others
Breakup by Region:
- North America
- Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
- Latin America
- Middle East and Africa
Competitive Landscape:
The report has also analysed the competitive landscape of the market with some of the key players being Asahi Kasei Zoll Medical Corporation, Biotronik, Boston Scientific Corporation, Koninklijke Philips N.V., LivaNova PLC, Medtronic Inc., Nihon Kohden Corporation, Schiller AG, Shenzhen Mindray Bio-Medical Electronics Co. Ltd., Stryker Corporation, etc.
Report Coverage:
Report Features |
Details |
Base Year of the Analysis |
2022 |
Historical Period |
2017-2022 |
Forecast Period |
2023-2028 |
Units |
US$ Billion |
Segment Coverage |
Product Type, End-User, Region |
Region Covered |
North America, Asia Pacific, Europe, Latin America, Middle East and Africa |
Countries Covered |
United States, Canada, China, Japan, India, South Korea, Australia, Indonesia, Germany, France, United Kingdom, Italy, Spain, Russia Brazil, Mexico |
Companies Covered |
Asahi Kasei Zoll Medical Corporation, Biotronik, Boston Scientific Corporation, Koninklijke Philips N.V., LivaNova PLC, Medtronic Inc., Nihon Kohden Corporation, Schiller AG, Shenzhen Mindray Bio-Medical Electronics Co. Ltd. and Stryker Corporation |
Customization Scope |
10% Free Customization |
Report Price and Purchase Option |
Single User License: US$ 2499
Five User License: US$ 3499
Corporate License: US$ 4499 |
Post-Sale Analyst Support |
10-12 Weeks |
Delivery Format |
PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |
Key Questions Answered in This Report:
- How has the global defibrillators market performed so far and how will it perform in the coming years?
- What are the key regional markets?
- What has been the impact of COVID-19 on the global defibrillators market?
- What is the breakup of the market based on the product type?
- What is the breakup of the market based on the end-user?
- What are the various stages in the value chain of the industry?
- What are the key driving factors and challenges in the industry?
- What is the structure of the global defibrillators market and who are the key players?
- What is the degree of competition in the industry?